GRI Bio, Inc.
GRI
$2.31
$0.062.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.06M | 5.07M | 4.48M | 4.84M | 4.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.98M | 11.27M | 10.03M | 9.39M | 8.24M |
| Operating Income | -11.98M | -11.27M | -10.03M | -9.39M | -8.24M |
| Income Before Tax | -11.96M | -11.25M | -10.01M | -9.37M | -8.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.96 | -11.25 | -10.01 | -9.37 | -8.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.96M | -11.25M | -10.01M | -9.37M | -8.21M |
| EBIT | -11.98M | -11.27M | -10.03M | -9.39M | -8.24M |
| EBITDA | -11.97M | -11.26M | -10.03M | -9.39M | -8.23M |
| EPS Basic | -248.16 | -454.94 | -419.06 | -382.34 | -220.02 |
| Normalized Basic EPS | -155.10 | -216.24 | -193.81 | -170.86 | -69.42 |
| EPS Diluted | -248.16 | -454.94 | -419.06 | -382.34 | -220.02 |
| Normalized Diluted EPS | -155.10 | -216.24 | -193.81 | -170.86 | -69.42 |
| Average Basic Shares Outstanding | 391.90K | 208.70K | 115.10K | 36.30K | 17.50K |
| Average Diluted Shares Outstanding | 391.90K | 208.70K | 115.10K | 36.30K | 17.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |